31-Oct-2012 | business & finance
Menarini Group and Oxford BioTherapeutics sign Major Strategic Collaboration for the Clinical Development and Manufacture of a Portfolio of Novel Antibody-Based Cancer Drugs
Menarini and Oxford BioTherapeutics (OBT) announced a major strategic alliance to develop a portfolio of antibody-based drugs in the field of cancer. The ...
